Evidence map›Paper›PMID 28070481›Full record

ArticleRespiratory medicine case reports2017

Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.

Nobumasa Ohara, Masanori Kaneko, Masahiro Ikeda, Fumio Ishizaki, Kazuya Suzuki, Ryo Maruyama, Takeshi Komeyama, Kazuhiro Sato, Kenichi Togashi, Hiroyuki Usuda and 4 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Nobumasa OharaDepartment of Endocrinology and Metabolism, Nagaoka Red Cross Hospital, Niigata, Japan; Department of Endocrinology and Metabolism, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.
Masanori KanekoDepartment of Endocrinology and Metabolism, Nagaoka Red Cross Hospital, Niigata, Japan.
Masahiro IkedaDepartment of Urology, Nagaoka Red Cross Hospital, Niigata, Japan.
Fumio IshizakiDepartment of Urology, Nagaoka Red Cross Hospital, Niigata, Japan.
Kazuya SuzukiDepartment of Urology, Nagaoka Red Cross Hospital, Niigata, Japan.
Ryo MaruyamaDepartment of Urology, Nagaoka Red Cross Hospital, Niigata, Japan.
Takeshi KomeyamaDepartment of Urology, Nagaoka Red Cross Hospital, Niigata, Japan.
Kazuhiro SatoDepartment of Respiratory Medicine, Nagaoka Red Cross Hospital, Niigata, Japan.
Kenichi TogashiDepartment of Thoracic Surgery, Nagaoka Red Cross Hospital, Niigata, Japan.
Hiroyuki UsudaDepartment of Pathology, Nagaoka Red Cross Hospital, Niigata, Japan.
Yuto YamazakiDepartment of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Hironobu SasanoDepartment of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Kenzo KanekoDepartment of Endocrinology and Metabolism, Nagaoka Red Cross Hospital, Niigata, Japan.
Kyuzi KamoiDepartment of Internal Medicine, Ojiya General Hospital, Niigata, Japan; Center of Diabetes, Endocrinology and Metabolism, Joetsu General Hospital, Niigata, Japan.
Nagaoka Red Cross Hospital · JPTohoku University · JPJōetsu General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder caused by heterozygous germline mutations in the tumor suppressor gene

Indexed as

ACC, adrenocortical carcinomaAdrenocortical carcinomaALK, anaplastic lymphoma kinaseCT, computed tomographyEGFR, epidermal growth factor receptorEpidermal growth factor receptor gene mutationImmunohistochemistryLAC, lung adenocarcinomaLung adenocarcinomaMEN1, multiple endocrine neoplasia type 1MeninMRI, magnetic resonance imagingMultiple endocrine neoplasia type 1SF-1, steroidogenic factorTTF-1, thyroid transcription factor-1

Identifiers

PMID28070481
PMCPMC5219631
OpenAlexW2564151063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.